About Abzena PLC (LON:ABZA)
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups. It offers immunogenicity assessment, which includes EpiScreen, iTope and T Cell Epitope Database (TCED); antibody drug conjugates, which includes ThioBridge linkers; antibody, which includes Composite Human Antibodies and Composite Proteins; optimization of pharmacokinetics, which includes TheraPEG, HiPEG conjugates PEG to poly-histidine motifs and CyPEG, and PolyPEG; cell line development, which includes Composite Human Antibody; process development, Good manufacturing practices (GMP) manufacturing, and small molecules. The Company's Abzena inside includes Composite Human Antibodies and ThioBridge Antibody Drug Conjugates (ADCs).
Industry, Sector and Symbol:
- Industry: Biotechnology & Medical Research
- Sub-Industry: N/A
- Sector: Biotechnology & Medical Research - NEC
- Symbol: LON:ABZA
- CUSIP: N/A
- Web: www.abzena.com
- Trailing EPS: GBX (0.07)
- Net Margins: -52.49%
- Return on Equity: -26.96%
- Return on Assets: -21.90%
- Outstanding Shares: 213,820,000
Frequently Asked Questions for Abzena PLC (LON:ABZA)
What is Abzena PLC's stock symbol?
Abzena PLC trades on the London Stock Exchange (LON) under the ticker symbol "ABZA."
Where is Abzena PLC's stock going? Where will Abzena PLC's stock price be in 2017?
2 analysts have issued 1-year target prices for Abzena PLC's stock. Their forecasts range from GBX 70 to GBX 80. On average, they anticipate Abzena PLC's share price to reach GBX 75 in the next twelve months. View Analyst Ratings for Abzena PLC.
Who are some of Abzena PLC's key competitors?
Some companies that are related to Abzena PLC include Advaxis (ADXS), Asterias Biotherapeutics (AST), ArQule (ARQL), Oramed Pharmaceuticals (ORMP), CTI BioPharma Corp. (CTIC), aTyr Pharma (LIFE), Eiger BioPharmaceuticals (EIGR), Matinas BioPharma Holdings (MTNB), Galectin Therapeutics (GALT), BioLineRx (BLRX), Infinity Pharmaceuticals (INFI), Novelion Therapeutics (NVLN), Sunesis Pharmaceuticals (SNSS), Regulus Therapeutics (RGLS), Brainstorm Cell Therapeutics (BCLI), NovaBay Pharmaceuticals (NBY), Navidea Biopharmaceuticals (NAVB) and Tissue Regenix Group PLC (TRX).
How do I buy Abzena PLC stock?
Shares of Abzena PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Abzena PLC's stock price today?
One share of Abzena PLC stock can currently be purchased for approximately GBX 32.25.
How big of a company is Abzena PLC?
Abzena PLC has a market capitalization of £67.5 million.
How can I contact Abzena PLC?
Abzena PLC's mailing address is Babraham Hall, Babraham Research, CAMBRIDGE, CB22 3AT, United Kingdom. The company can be reached via phone at +44-1223-903498.
MarketBeat Community Rating for Abzena PLC (LON ABZA)MarketBeat's community ratings are surveys of what our community members think about Abzena PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Abzena PLC (LON:ABZA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 75|
Consensus Price Target History for Abzena PLC (LON:ABZA)
Analysts' Ratings History for Abzena PLC (LON:ABZA)
(Data available from 11/20/2015 forward)
|9/22/2017||FinnCap||Lower Price Target||Buy||GBX 80 -> GBX 70|
|9/14/2017||Numis Securities Ltd||Reiterated Rating||Buy||GBX 80|
|4/26/2017||N+1 Singer||Reiterated Rating||Corporate|
Earnings History for Abzena PLC (LON:ABZA)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Abzena PLC (LON:ABZA)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Abzena PLC (LON:ABZA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Abzena PLC (LON ABZA)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for Abzena PLC (LON ABZA)
Financials are not available for this stock.
Abzena PLC (LON ABZA) Chart for Monday, November, 20, 2017